138 related articles for article (PubMed ID: 25044383)
1. Pentoxifylline does not alter the concentration of hepcidin in chronic kidney disease patients undergoing hemodialysis.
Antunes SA; Vilela RQ; Vaz JD; Canziani ME
Int J Artif Organs; 2014 Jul; 37(7):521-8. PubMed ID: 25044383
[TBL] [Abstract][Full Text] [Related]
2. Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P;
Nephrology (Carlton); 2017 Jul; 22(7):548-554. PubMed ID: 27171136
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM;
Am J Kidney Dis; 2015 Jan; 65(1):49-57. PubMed ID: 25115616
[TBL] [Abstract][Full Text] [Related]
4. Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease.
Chand S; Ward DG; Ng ZY; Hodson J; Kirby H; Steele P; Rooplal I; Bantugon F; Iqbal T; Tselepis C; Drayson MT; Whitelegg A; Chowrimootoo M; Borrows R
J Nephrol; 2015 Feb; 28(1):81-8. PubMed ID: 24687402
[TBL] [Abstract][Full Text] [Related]
5. Association of hepcidin and anemia in early chronic kidney disease.
Sonkar SK; Singh NK; Sonkar GK; Pandey S; Bhosale V; Kumar A; Usman K
Saudi J Kidney Dis Transpl; 2019; 30(2):315-324. PubMed ID: 31031367
[TBL] [Abstract][Full Text] [Related]
6. Hepcidin/Ferritin Ratios Differ Among Non-Dialyzed Chronic Kidney Disease Patients, and Patients on Hemodialysis and Peritoneal Dialysis.
Niikura T; Maruyama Y; Nakashima S; Matsuo N; Tanno Y; Ohkido I; Yokoyama K; Yamamoto H; Yokoo T
Ther Apher Dial; 2019 Aug; 23(4):341-346. PubMed ID: 30411489
[TBL] [Abstract][Full Text] [Related]
7. Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).
Lee SW; Kim YH; Chung W; Park SK; Chae DW; Ahn C; Kim YS; Sung SA
Kidney Blood Press Res; 2017; 42(6):1183-1192. PubMed ID: 29227972
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin-25, mean corpuscular volume, and ferritin as predictors of response to oral iron supplementation in hemodialysis patients.
Takasawa K; Takaeda C; Maeda T; Ueda N
Nutrients; 2014 Dec; 7(1):103-18. PubMed ID: 25551249
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Bolignano D; D'Arrigo G; Pisano A; Coppolino G
PLoS One; 2015; 10(8):e0134104. PubMed ID: 26237421
[TBL] [Abstract][Full Text] [Related]
10. A randomized, 29-day, dose-ranging, efficacy and safety study of daprodustat, administered three times weekly in patients with anemia on hemodialysis.
Bailey CK; Caltabiano S; Cobitz AR; Huang C; Mahar KM; Patel VV
BMC Nephrol; 2019 Oct; 20(1):372. PubMed ID: 31619187
[TBL] [Abstract][Full Text] [Related]
11. Enarodustat, Conversion and Maintenance Therapy for Anemia in Hemodialysis Patients: A Randomized, Placebo-Controlled Phase 2b Trial Followed by Long-Term Trial.
Akizawa T; Nangaku M; Yamaguchi T; Arai M; Koretomo R; Maeda K; Miyazawa Y; Hirakata H
Nephron; 2019; 143(2):77-85. PubMed ID: 31117088
[TBL] [Abstract][Full Text] [Related]
12. Significance of Content of the Reticulocyte Hemoglobin in the Management of Renal Anemia.
Ogawa C; Tsuchiya K; Nitta K; Maeda K
Blood Purif; 2019; 47 Suppl 2():70-73. PubMed ID: 30943480
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
Ferrari P; Mallon D; Trinder D; Olynyk JK
Nephrology (Carlton); 2010 Apr; 15(3):344-9. PubMed ID: 20470305
[TBL] [Abstract][Full Text] [Related]
14. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
[TBL] [Abstract][Full Text] [Related]
15. Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients.
Sany D; Elsawy AE; Elshahawy Y
Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):967-73. PubMed ID: 25193892
[TBL] [Abstract][Full Text] [Related]
16. Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease.
Martin ER; Smith MT; Maroni BJ; Zuraw QC; deGoma EM
Am J Nephrol; 2017; 45(5):380-388. PubMed ID: 28343225
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
[TBL] [Abstract][Full Text] [Related]
18. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
[TBL] [Abstract][Full Text] [Related]
19. Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients.
Yamamoto M; Matsumoto T; Ohmori H; Takemoto M; Ikeda M; Sumimoto R; Kobayashi T; Kato A; Ohdan H
BMC Nephrol; 2021 Jun; 22(1):221. PubMed ID: 34126941
[TBL] [Abstract][Full Text] [Related]
20. Functional erythropoietin-hepcidin axis in recombinant human erythropoietin independent haemodialysis patients.
Touzot M; Lefebvre T; Roux A; Maheas C; Ridel C; Puy H; Karim Z
Nephrology (Carlton); 2019 Jul; 24(7):751-757. PubMed ID: 30175513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
